Datasets:
ensembl_id string | gene string | gene_description string | uniprot list | chromosome string | position string | evidence string | hpa_evidence string | uniprot_evidence string | nextprot_evidence string | antibodies list | gene_synonyms list | protein_classes list | biological_processes list | molecular_functions list | disease_involvement list | subcellular_main_locations list | subcellular_additional_locations list | secretome_locations list | secretome_functions list | reliability_if string | reliability_ih string | reliability_mouse_brain string | interactions float64 | ccd_protein string | ccd_transcript string | blood_expression_cluster string | brain_expression_cluster string | cell_line_expression_cluster string | single_cell_expression_cluster string | tissue_expression_cluster string | rna_tissue_specificity string | rna_tissue_distribution string | rna_tissue_specificity_score float64 | rna_cell_line_specificity string | rna_cell_line_distribution string | rna_cell_line_specificity_score float64 | rna_cancer_specificity string | rna_cancer_distribution string | rna_cancer_specificity_score float64 | rna_single_cell_type_specificity string | rna_single_cell_type_distribution string | rna_single_cell_type_specificity_score float64 | rna_blood_cell_specificity string | rna_blood_cell_distribution string | rna_blood_cell_specificity_score float64 | prognostic_cancer_count int64 | validated_prognostic_cancer_count int64 | potential_prognostic_cancer_count int64 | favorable_prognostic_cancers list | unfavorable_prognostic_cancers list | prognostic_cancers list | source_row_index int64 | split_bucket int64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ENSG00000000003 | TSPAN6 | Tetraspanin 6 | [
"O43657"
] | X | 100627108-100639991 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA004109"
] | [
"T245",
"TM4SF6",
"TSPAN-6"
] | [
"Predicted membrane proteins"
] | [] | [] | [] | [
"Cell Junctions",
"Cytosol"
] | [
"Nucleoli fibrillar center"
] | [] | [] | Approved | Approved | null | 2 | null | null | Cluster 43: Non-specific - Transcription & Translation | Cluster 3: Choroid plexus - Cilium | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 23: Elongating spermatids - Sperm cell metabolism & fertilization | Cluster 56: Ciliated tissues - Cilium organization | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Group enriched | Detected in many | 5 | Immune cell enhanced | Detected in some | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Head and Neck Squamous Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 0 | 6 |
ENSG00000000005 | TNMD | Tenomodulin | [
"Q9H2S6"
] | X | 100584936-100599885 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA034961",
"HPA055634"
] | [
"BRICD4",
"ChM1L",
"myodulin",
"TEM",
"tendin"
] | [
"Predicted membrane proteins"
] | [] | [] | [] | [] | [] | [] | [] | null | Uncertain | null | 1 | null | null | null | Cluster 36: Choroid plexus - Mixed function | Cluster 34: Testis cancer - Unknown function | Cluster 94: Gonadal somatic cells - Mixed function | Cluster 14: Adipose tissue - Angiogenesis | Tissue enhanced | Detected in some | null | Group enriched | Detected in some | 5 | Low cancer specificity | Detected in some | null | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 1 | 3 |
ENSG00000000419 | DPM1 | Dolichyl-phosphate mannosyltransferase subunit 1, catalytic | [
"O60762"
] | 20 | 50934867-50959140 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA051818"
] | [
"CDGIE",
"MPDS"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Metabolic proteins",
"Plasma proteins",
"Potential drug targets",
"Predicted intracellular proteins"
] | [] | [
"Glycosyltransferase",
"Transferase"
] | [
"Congenital disorder of glycosylation",
"Congenital muscular dystrophy",
"Disease variant",
"Dystroglycanopathy"
] | [] | [] | [] | [] | null | Approved | null | 22 | null | null | Cluster 33: Non-specific - ATP binding | Cluster 21: Non-specific - Metabolism | Cluster 62: Non-specific - Plasma proteins | Cluster 39: Syncytiotrophoblasts - Placental homeostasis & endocrine signal | Cluster 76: Non-specific - Metabolism | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 3 | 2 | 2 | [] | [
"Head and Neck Squamous Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Thyroid Carcinoma"
] | [
"Head and Neck Squamous Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Thyroid Carcinoma"
] | 2 | 6 |
ENSG00000000457 | SCYL3 | SCY1 like pseudokinase 3 | [
"Q8IZE3"
] | 1 | 169849631-169894267 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA005624",
"HPA072383"
] | [
"PACE-1",
"PACE1"
] | [
"Enzymes",
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Golgi apparatus",
"Cytosol"
] | [] | [] | [] | Supported | Approved | null | 23 | null | null | Cluster 5: Non-specific - Cell proliferation | Cluster 50: Non-specific - Nucleic acid binding | Cluster 45: Non-specific - Nuclear processes | Cluster 71: Non-specific - Cardiac endocrine signaling & maintenanc | Cluster 61: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in all | null | 0 | 0 | 0 | [] | [] | [] | 3 | 8 |
ENSG00000000460 | C1orf112 | Chromosome 1 open reading frame 112 | [
"Q9NSG2"
] | 1 | 169662007-169854080 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA023778",
"HPA024451"
] | [
"FLJ10706"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Nucleoplasm"
] | [
"Nucleoli"
] | [] | [] | Supported | Uncertain | null | 16 | null | null | Cluster 10: Non-specific - Membrane trafficking | Cluster 55: Non-specific - Transcription | Cluster 45: Non-specific - Nuclear processes | Cluster 71: Non-specific - Cardiac endocrine signaling & maintenanc | Cluster 61: Non-specific - Transcription | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 2 | 4 | 0 | [] | [
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 4 | 7 |
ENSG00000000938 | FGR | FGR proto-oncogene, Src family tyrosine kinase | [
"P09769"
] | 1 | 27612064-27635185 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA002024"
] | [
"c-fgr",
"p55c-fgr",
"SRC2"
] | [
"Disease related genes",
"Enzymes",
"Plasma proteins",
"Potential drug targets",
"Predicted intracellular proteins"
] | [
"Immunity",
"Innate immunity"
] | [
"Kinase",
"Transferase",
"Tyrosine-protein kinase"
] | [
"Proto-oncogene"
] | [
"Plasma membrane"
] | [
"Aggresome"
] | [] | [] | Approved | Enhanced | null | 16 | null | null | Cluster 37: Monocytes & Neutrophils - Innate immune response | Cluster 47: Endothelial cells - Vasculature | Cluster 55: Lymphoma - Immune response | Cluster 40: Monocytes & Neutrophils - Inflammatory signaling | Cluster 29: Lymphoid tissue & Bone marrow - Innate immune response | Group enriched | Detected in many | 6 | Group enriched | Detected in some | 16 | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in some | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Breast Invasive Carcinoma"
] | [
"Rectum Adenocarcinoma"
] | [
"Breast Invasive Carcinoma",
"Rectum Adenocarcinoma"
] | 5 | 6 |
ENSG00000000971 | CFH | Complement factor H | [
"P08603"
] | 1 | 196651754-196752476 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB016385",
"CAB016769",
"HPA038922",
"HPA049176",
"HPA053326"
] | [
"ARMD4",
"ARMS1",
"FHL1",
"HF",
"HF1",
"HF2",
"HUS"
] | [
"Cancer-related genes",
"Disease related genes",
"Human disease related genes",
"Plasma proteins",
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [
"Complement alternate pathway",
"Host-virus interaction",
"Immunity",
"Innate immunity"
] | [] | [
"Age-related macular degeneration",
"Cancer-related genes",
"Disease variant",
"Hemolytic uremic syndrome"
] | [
"Vesicles"
] | [] | [
"Secreted to blood"
] | [
"Immunity"
] | Approved | Supported | null | 9 | null | null | Cluster 1: T-cells - Unknown function | Cluster 42: Choroid plexus - Mitochondria | Cluster 71: Lymphoma - Inflammatory response | Cluster 104: Brain endothelial cells - Blood brain barrier | Cluster 45: Liver - Metabolism & Coagulation | Tissue enriched | Detected in all | 5 | Cancer enhanced | Detected in many | null | Cancer enriched | Detected in all | 8 | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in some | null | 1 | 0 | 1 | [] | [
"Glioblastoma Multiforme"
] | [
"Glioblastoma Multiforme"
] | 6 | 6 |
ENSG00000001036 | FUCA2 | Alpha-L-fucosidase 2 | [
"Q9BTY2"
] | 6 | 143494812-143511720 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA031659",
"HPA031661"
] | [
"dJ20N2.5",
"MGC1314"
] | [
"Enzymes",
"Metabolic proteins",
"Plasma proteins",
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [] | [
"Glycosidase",
"Hydrolase"
] | [] | [] | [] | [
"Secreted to blood"
] | [
"Enzyme"
] | null | Approved | null | 16 | null | null | Cluster 38: Monocytes & Neutrophils - Degranulation | Cluster 50: Non-specific - Nucleic acid binding | Cluster 28: Non-specific - Nuclear processes | Cluster 8: Non-specific - Secretory pathway | Cluster 69: Parathyroid gland - Mixed function | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 4 | 2 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Glioblastoma Multiforme",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | 7 | 9 |
ENSG00000001084 | GCLC | Glutamate-cysteine ligase catalytic subunit | [
"P48506"
] | 6 | 53497341-53616970 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB009569",
"HPA036359",
"HPA036360"
] | [
"GCS",
"GLCL",
"GLCLC"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Metabolic proteins",
"Plasma proteins",
"Potential drug targets",
"Predicted intracellular proteins"
] | [
"Glutathione biosynthesis"
] | [
"Ligase"
] | [
"Disease variant",
"Hereditary hemolytic anemia"
] | [
"Nucleoplasm"
] | [
"Nucleoli",
"Cytosol"
] | [] | [] | Approved | Approved | null | 7 | null | null | Cluster 41: Basophils - Unknown function | Cluster 13: Oligodendrocytes - Mixed function | Cluster 7: Liver cancer - Metabolism | Cluster 69: Urothelial cells - Basic cellular functions | Cluster 45: Liver - Metabolism & Coagulation | Tissue enhanced | Detected in all | null | Cancer enhanced | Detected in all | null | Cancer enhanced | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in many | null | 4 | 0 | 4 | [
"Kidney Renal Clear Cell Carcinoma",
"Rectum Adenocarcinoma"
] | [
"Kidney Renal Papillary Cell Carcinoma",
"Lung Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Lung Adenocarcinoma",
"Rectum Adenocarcinoma"
] | 8 | 2 |
ENSG00000001167 | NFYA | Nuclear transcription factor Y subunit alpha | [
"P23511"
] | 6 | 41072974-41102403 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB009250",
"HPA050779"
] | [
"CBF-B",
"HAP2",
"NF-YA"
] | [
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Biological rhythms",
"Transcription",
"Transcription regulation"
] | [
"Activator",
"DNA-binding"
] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Supported | Enhanced | null | 32 | null | null | Cluster 33: Non-specific - ATP binding | Cluster 11: White matter - Signal transduction | Cluster 28: Non-specific - Nuclear processes | Cluster 48: Neutrophils - Phagocytosis & degranulation | Cluster 59: Lymphoid tissue & Bone marrow - Cell proliferation | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 9 | 8 |
ENSG00000001460 | STPG1 | Sperm tail PG-rich repeat containing 1 | [
"Q5TH74"
] | 1 | 24356999-24416934 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA024301"
] | [
"C1orf201",
"FLJ33340",
"MAPO2"
] | [
"Predicted intracellular proteins"
] | [
"Apoptosis"
] | [] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Approved | null | null | null | null | null | Cluster 12: Non-specific - Mitochondrial translation | Cluster 52: Neurons & Synapses - Synaptic function | Cluster 37: Non-specific - mRNA processing | Cluster 23: Elongating spermatids - Sperm cell metabolism & fertilization | Cluster 48: Ciliated tissues - Cilium organization | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Group enriched | Detected in many | 4 | Low immune cell specificity | Detected in some | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Glioblastoma Multiforme"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | 10 | 3 |
ENSG00000001461 | NIPAL3 | NIPA like domain containing 3 | [
"Q6P499"
] | 1 | 24415802-24472976 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA039978"
] | [
"DJ462O23.2",
"NPAL3",
"SLC57A5"
] | [
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Transporters"
] | [] | [] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Approved | Approved | null | 13 | null | null | Cluster 5: Non-specific - Cell proliferation | Cluster 26: Oligodendrocytes - Mixed function | Cluster 64: Connective tissue cells - ECM organization | Cluster 16: Prostatic glandular cells - Androgen response & seminal fluid | Cluster 3: Oligodendrocytes - Myelination | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enriched | Detected in many | 4 | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 11 | 1 |
ENSG00000001497 | LAS1L | LAS1 like ribosome biogenesis factor | [
"Q9Y4W2"
] | X | 65438549-65534810 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA044431",
"HPA061463"
] | [
"FLJ12525",
"Las1"
] | [
"Disease related genes",
"Essential proteins",
"Human disease related genes",
"Predicted intracellular proteins"
] | [
"rRNA processing"
] | [
"Hydrolase"
] | [
"Disease variant",
"Intellectual disability",
"Obesity"
] | [
"Nucleoplasm"
] | [
"Primary cilium transition zone",
"Centriolar satellite",
"Centrosome",
"Basal body",
"Cytosol"
] | [] | [] | Approved | Supported | null | 51 | null | null | Cluster 13: Non-specific - Mitochondria | Cluster 13: Oligodendrocytes - Mixed function | Cluster 36: Non-specific - mRNA processing | Cluster 56: Late spermatids - Spermiogenesis: Maturation | Cluster 3: Oligodendrocytes - Myelination | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Glioblastoma Multiforme",
"Testicular Germ Cell Tumor"
] | [] | [
"Glioblastoma Multiforme",
"Testicular Germ Cell Tumor"
] | 12 | 8 |
ENSG00000001561 | ENPP4 | Ectonucleotide pyrophosphatase/phosphodiesterase 4 | [
"Q9Y6X5"
] | 6 | 46129989-46146688 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA016594"
] | [
"AP3Aase",
"KIAA0879",
"NPP4"
] | [
"Enzymes",
"Predicted membrane proteins"
] | [
"Blood coagulation",
"Hemostasis"
] | [
"Hydrolase"
] | [] | [] | [] | [] | [] | null | Approved | null | 11 | null | null | Cluster 3: Non-specific - Nuclear processes | Cluster 28: Oligodendrocytes - Mixed function | Cluster 15: Kidney cancer - Membrane components | Cluster 37: Neutrophil progenitors - Granulopoiesis | Cluster 25: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 2 | 2 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Lung Squamous Cell Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Lung Squamous Cell Carcinoma"
] | 13 | 4 |
ENSG00000001617 | SEMA3F | Semaphorin 3F | [
"Q13275"
] | 3 | 50155045-50189075 | Evidence at protein level | Evidence at transcript level | Evidence at transcript level | Evidence at protein level | [
"HPA035008"
] | [
"Sema4",
"SEMAK"
] | [
"Plasma proteins",
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [] | [] | [] | [] | [] | [
"Secreted to blood"
] | [
"Developmental protein"
] | null | Approved | null | null | null | null | null | Cluster 38: Sub-cortical - Mixed function | Cluster 48: Adipocytes & Endothelial cells - Angiogenesis | Cluster 32: Endothelial cells - Angiogenesis & vascular immunity | Cluster 81: Squamous epithelium - Keratinization | Tissue enhanced | Detected in all | null | Cancer enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Glioblastoma Multiforme",
"Liver Hepatocellular Carcinoma"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 14 | 2 |
ENSG00000001626 | CFTR | CF transmembrane conductance regulator | [
"P13569"
] | 7 | 117287120-117715971 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB001951",
"HPA021939",
"HPA079652"
] | [
"ABC35",
"ABCC7",
"CF",
"CFTR/MRP",
"dJ760C5.1",
"MRP7",
"TNR-CFTR"
] | [
"Cancer-related genes",
"Disease related genes",
"Enzymes",
"FDA approved drug targets",
"Human disease related genes",
"Plasma proteins",
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Transporters"
] | [
"Ion transport",
"Transport"
] | [
"Chloride channel",
"Ion channel",
"Isomerase"
] | [
"Cancer-related genes",
"Disease variant",
"FDA approved drug targets"
] | [] | [] | [] | [] | null | Enhanced | null | 373 | null | null | null | Cluster 11: White matter - Signal transduction | Cluster 57: Stomach & Colon cancer - Digestion | Cluster 38: Secretory epithelial cells - Exocrine secretion | Cluster 8: Pancreas - Proteolysis | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Group enriched | Detected in many | 4 | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 2 | 0 | 2 | [
"Colon Adenocarcinoma",
"Lung Adenocarcinoma"
] | [] | [
"Colon Adenocarcinoma",
"Lung Adenocarcinoma"
] | 15 | 2 |
ENSG00000001630 | CYP51A1 | Cytochrome P450 family 51 subfamily A member 1 | [
"Q16850"
] | 7 | 92084987-92134803 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA041325",
"HPA043508"
] | [
"CP51",
"CYP51",
"CYPL1",
"LDM",
"P450-14DM",
"P450L1"
] | [
"Enzymes",
"FDA approved drug targets",
"Metabolic proteins",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Cholesterol biosynthesis",
"Cholesterol metabolism",
"Lipid biosynthesis",
"Lipid metabolism",
"Steroid biosynthesis",
"Steroid metabolism",
"Sterol biosynthesis",
"Sterol metabolism"
] | [
"Monooxygenase",
"Oxidoreductase"
] | [
"FDA approved drug targets"
] | [
"Endoplasmic reticulum"
] | [] | [] | [] | Approved | Approved | null | 14 | null | null | Cluster 13: Non-specific - Mitochondria | Cluster 49: Hindbrain - Mixed function | Cluster 57: Stomach & Colon cancer - Digestion | Cluster 83: Epicardial mesothelial cells - Basic cellular functions | Cluster 76: Non-specific - Metabolism | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Chromophobe"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma"
] | 17 | 9 |
ENSG00000001631 | KRIT1 | KRIT1 ankyrin repeat containing | [
"O00522"
] | 7 | 92197498-92246166 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA049606"
] | [
"CAM",
"CCM1"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [
"Angiogenesis"
] | [] | [
"Disease variant"
] | [
"Vesicles"
] | [] | [] | [] | Uncertain | Supported | null | 12 | null | null | Cluster 5: Non-specific - Cell proliferation | Cluster 55: Non-specific - Transcription | Cluster 39: Non-specific - Transcription | Cluster 105: Non-specific - Mixed function | Cluster 69: Parathyroid gland - Mixed function | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Group enriched | Detected in many | 9 | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Chromophobe",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 18 | 8 |
ENSG00000002016 | RAD52 | RAD52 homolog, DNA repair protein | [
"P43351"
] | 12 | 911736-990053 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA028957"
] | [] | [
"Cancer-related genes",
"Predicted intracellular proteins"
] | [
"DNA damage",
"DNA recombination",
"DNA repair"
] | [
"DNA-binding"
] | [
"Cancer-related genes"
] | [
"Nuclear speckles"
] | [
"Plasma membrane"
] | [] | [] | Approved | null | null | 24 | null | null | Cluster 5: Non-specific - Cell proliferation | Cluster 11: White matter - Signal transduction | Cluster 38: Non-specific - Transcription | Cluster 36: Skeletal myocytes - Muscle excitation & contraction | Cluster 63: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Rectum Adenocarcinoma"
] | [
"Kidney Chromophobe"
] | [
"Kidney Chromophobe",
"Rectum Adenocarcinoma"
] | 19 | 7 |
ENSG00000002330 | BAD | BCL2 associated agonist of cell death | [
"Q92934"
] | 11 | 64269830-64284704 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB004205",
"HPA028185",
"HPA062105"
] | [
"BBC2",
"BCL2L8"
] | [
"Cancer-related genes",
"Predicted intracellular proteins",
"RAS pathway related proteins"
] | [
"Apoptosis"
] | [] | [
"Cancer-related genes"
] | [
"Mitochondria"
] | [
"Principal piece",
"End piece"
] | [] | [] | Enhanced | Approved | null | 44 | null | null | Cluster 29: Non-specific - Unknown function | Cluster 27: Non-specific - Mixed function | Cluster 24: Non-specific - Unknown function | Cluster 13: Syncytiotrophoblasts - Placental remodeling & endocrine func. | Cluster 68: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 20 | 3 |
ENSG00000002549 | LAP3 | Leucine aminopeptidase 3 | [
"P28838"
] | 4 | 17577198-17607972 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA029606",
"HPA029607"
] | [
"LAP",
"LAPEP",
"PEPS"
] | [
"Enzymes",
"Metabolic proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [] | [
"Aminopeptidase",
"Hydrolase",
"Protease"
] | [] | [
"Cytosol"
] | [
"Calyx",
"Mid piece",
"Principal piece"
] | [] | [] | Approved | Enhanced | null | 15 | null | No | Cluster 10: Non-specific - Membrane trafficking | Cluster 19: Astrocytes - Mixed function | Cluster 31: Non-specific - Antiviral immune response | Cluster 32: Endothelial cells - Angiogenesis & vascular immunity | Cluster 66: Lymphoid tissue - Immune response | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 21 | 1 |
ENSG00000002586 | CD99 | CD99 molecule (Xg blood group) | [
"P14209"
] | X | 2691187-2741309 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB000020",
"HPA035304"
] | [
"MIC2"
] | [
"CD markers",
"Plasma proteins",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Cell adhesion"
] | [] | [] | [
"Golgi apparatus"
] | [] | [] | [] | Approved | Supported | null | 3 | null | null | Cluster 13: Non-specific - Mitochondria | Cluster 39: Astrocytes - Mixed function | Cluster 12: Bone cancer - Neuronal signaling | Cluster 108: Fibroblasts - ECM organization | Cluster 12: Smooth muscle tissue - ECM organization | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 2 | 0 | [] | [
"Lung Adenocarcinoma"
] | [
"Lung Adenocarcinoma"
] | 22 | 3 |
ENSG00000002587 | HS3ST1 | Heparan sulfate-glucosamine 3-sulfotransferase 1 | [
"O14792"
] | 4 | 11393150-11429564 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA002237"
] | [
"3OST1"
] | [
"Enzymes",
"Metabolic proteins",
"Predicted intracellular proteins"
] | [] | [
"Transferase"
] | [] | [
"Vesicles"
] | [] | [
"Intracellular and membrane"
] | [
"Enzyme"
] | Approved | Approved | null | 28 | null | null | Cluster 8: Plasmacytoid DCs - Unknown function | Cluster 35: Non-specific - DNA binding | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 100: Stratified epithelial cells - Barrier functions | Cluster 75: Ovary - Mixed function | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Group enriched | Detected in some | 36 | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 23 | 4 |
ENSG00000002726 | AOC1 | Amine oxidase copper containing 1 | [
"P19801"
] | 7 | 150824627-150861504 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA031032",
"HPA031033"
] | [
"ABP",
"ABP1",
"DAO"
] | [
"Enzymes",
"Metabolic proteins",
"Predicted secreted proteins"
] | [] | [
"Heparin-binding",
"Oxidoreductase"
] | [] | [] | [] | [
"Secreted in other tissues"
] | [
"Enzyme"
] | null | Approved | null | 8 | null | null | Cluster 36: Eosinophils - Protein ubiquitination | Cluster 46: Brainstem - Mixed function | Cluster 57: Stomach & Colon cancer - Digestion | Cluster 45: Colonocytes & Enterocytes - Gastrointestinal absorption & barrier | Cluster 26: Kidney & Intestine - Metabolism | Group enriched | Detected in many | 16 | Cancer enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in many | null | Immune cell enriched | Detected in some | 12 | 2 | 2 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Uterine Corpus Endometrial Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Uterine Corpus Endometrial Carcinoma"
] | 24 | 7 |
ENSG00000002745 | WNT16 | Wnt family member 16 | [
"Q9UBV4"
] | 7 | 121325367-121341104 | Evidence at protein level | Evidence at transcript level | Evidence at transcript level | Evidence at protein level | [] | [] | [
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [
"Wnt signaling pathway"
] | [
"Developmental protein"
] | [] | [] | [] | [
"Secreted to extracellular matrix"
] | [
"Developmental protein"
] | null | null | null | null | null | null | Cluster 23: B-cells - Immunoglobulins | Cluster 23: Choroid plexus - Mixed function | Cluster 6: Leukemia - Signal transduction | Cluster 87: B-cells - Adaptive immunity: Humoral response | Cluster 37: Skin - Keratinization | Group enriched | Detected in some | 4 | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in some | null | Cell type enhanced | Detected in some | null | Group enriched | Detected in some | 145 | 1 | 0 | 1 | [] | [
"Glioblastoma Multiforme"
] | [
"Glioblastoma Multiforme"
] | 25 | 1 |
ENSG00000002746 | HECW1 | HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1 | [
"Q76N89"
] | 7 | 43112629-43566001 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA007203",
"HPA007593",
"HPA007609"
] | [
"KIAA0322",
"NEDL1"
] | [
"Enzymes",
"Metabolic proteins",
"Predicted intracellular proteins"
] | [
"Ubl conjugation pathway"
] | [
"Transferase"
] | [] | [
"Nucleoli fibrillar center"
] | [
"Cytosol"
] | [] | [] | Approved | Uncertain | null | 6 | null | null | Cluster 20: Non-specific - DNA binding | Cluster 14: Neurons - Synaptic function | Cluster 7: Liver cancer - Metabolism | Cluster 109: Neurons - Neuronal signaling | Cluster 36: Brain & Liver - Signaling | Tissue enhanced | Detected in some | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in some | null | 2 | 0 | 2 | [
"Glioblastoma Multiforme"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Glioblastoma Multiforme"
] | 26 | 5 |
ENSG00000002822 | MAD1L1 | Mitotic arrest deficient 1 like 1 | [
"Q9Y6D9"
] | 7 | 1815793-2233243 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA003635",
"CAB015338"
] | [
"HsMAD1",
"MAD1",
"PIG9",
"TP53I9",
"TXBP181"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [
"Cell cycle",
"Cell division",
"Mitosis"
] | [] | [
"Disease variant"
] | [
"Nucleoplasm",
"Nuclear membrane"
] | [] | [] | [] | Supported | Supported | null | 61 | null | null | Cluster 9: T-regs - Cell cycle regulation | Cluster 11: White matter - Signal transduction | Cluster 67: Non-specific - Unknown function | Cluster 102: Non-specific - Mixed function | Cluster 68: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cancer enhanced | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Kidney Renal Papillary Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | 27 | 3 |
ENSG00000002834 | LASP1 | LIM and SH3 protein 1 | [
"Q14847"
] | 17 | 38869859-38921770 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA012072",
"CAB022049"
] | [
"Lasp-1",
"MLN50"
] | [
"Cancer-related genes",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Ion transport",
"Transport"
] | [
"Actin-binding"
] | [
"Cancer-related genes"
] | [
"Plasma membrane",
"Cytosol"
] | [
"Golgi apparatus",
"Focal adhesion sites"
] | [] | [] | Approved | Enhanced | null | 35 | null | null | Cluster 38: Monocytes & Neutrophils - Degranulation | Cluster 38: Sub-cortical - Mixed function | Cluster 27: Breast cancer - Unknown function | Cluster 29: Neutrophils - Innate immune cellular maintenance | Cluster 77: Intestine - Digestion | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 4 | 0 | 4 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | 28 | 5 |
ENSG00000002919 | SNX11 | Sorting nexin 11 | [
"Q9Y5W9"
] | 17 | 48103357-48123601 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA044787",
"HPA054660"
] | [] | [
"Predicted intracellular proteins"
] | [
"Protein transport",
"Transport"
] | [] | [] | [
"Endoplasmic reticulum"
] | [
"Vesicles"
] | [] | [] | Approved | Approved | null | 10 | null | null | Cluster 28: Neutrophils - Unknown function | Cluster 13: Oligodendrocytes - Mixed function | Cluster 55: Lymphoma - Immune response | Cluster 97: Non-specific - Cellular respiration | Cluster 18: Lymphoid tissue - Immune response | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | 29 | 5 |
ENSG00000002933 | TMEM176A | Transmembrane protein 176A | [
"Q96HP8"
] | 7 | 150800403-150805118 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA008770"
] | [
"HCA112",
"MS4B1"
] | [
"Predicted membrane proteins",
"Transporters"
] | [] | [] | [] | [
"Mitochondria"
] | [] | [] | [] | Approved | Approved | null | 12 | null | null | Cluster 26: Monocytes - Plasma membrane proteins | Cluster 22: Non-specific - Mixed function | Cluster 64: Connective tissue cells - ECM organization | Cluster 1: Enterocytes - Absorption and Digestion | Cluster 16: Liver & Kidney - Metabolism | Group enriched | Detected in all | 4 | Cancer enhanced | Detected in many | null | Cancer enhanced | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in many | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Rectum Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Rectum Adenocarcinoma"
] | 30 | 4 |
ENSG00000003056 | M6PR | Mannose-6-phosphate receptor, cation dependent | [
"P20645"
] | 12 | 8940361-8949761 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB034464",
"HPA040445"
] | [
"CD-M6PR",
"CD-MPR"
] | [
"FDA approved drug targets",
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Transporters"
] | [
"Transport"
] | [
"Receptor"
] | [
"FDA approved drug targets"
] | [] | [] | [] | [] | null | Approved | null | 14 | null | null | Cluster 42: Non-specific - Vesicular transport | Cluster 21: Non-specific - Metabolism | Cluster 38: Non-specific - Transcription | Cluster 72: Macrophages - Phagocytosis & lysosomal degradation | Cluster 18: Lymphoid tissue - Immune response | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 31 | 1 |
ENSG00000003096 | KLHL13 | Kelch like family member 13 | [
"Q9P2N7"
] | X | 117897813-118117340 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA046039",
"HPA059901"
] | [
"BKLHD2",
"FLJ10262",
"KIAA1309"
] | [
"Predicted intracellular proteins"
] | [
"Cell cycle",
"Cell division",
"Mitosis",
"Ubl conjugation pathway"
] | [] | [] | [
"Cytosol"
] | [] | [] | [] | Approved | Approved | null | 14 | null | null | Cluster 22: Eosinophils - Transcription | Cluster 38: Sub-cortical - Mixed function | Cluster 17: Neuroblastoma - Neuronal signaling | Cluster 50: Renal epithelial cells - Ion transport and pH regulation | Cluster 75: Ovary - Mixed function | Tissue enhanced | Detected in many | null | Group enriched | Detected in many | 5 | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in some | null | 4 | 0 | 4 | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Stomach Adenocarcinoma"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Stomach Adenocarcinoma"
] | 32 | 8 |
ENSG00000003137 | CYP26B1 | Cytochrome P450 family 26 subfamily B member 1 | [
"Q9NR63"
] | 2 | 72129238-72147862 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA012567"
] | [
"P450RAI-2"
] | [
"Disease related genes",
"Metabolic proteins",
"Predicted intracellular proteins"
] | [
"Lipid metabolism"
] | [
"Monooxygenase",
"Oxidoreductase"
] | [
"Craniosynostosis",
"Disease variant"
] | [
"Cytosol"
] | [] | [] | [] | Approved | Uncertain | null | 14 | No | No | null | Cluster 49: Hindbrain - Mixed function | Cluster 5: Rhabdoid - Unknown function | Cluster 94: Gonadal somatic cells - Mixed function | Cluster 2: Non-specific - Mixed function | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Group enriched | Detected in many | 5 | Not detected in immune cells | Not detected | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 33 | 9 |
ENSG00000003147 | ICA1 | Islet cell autoantigen 1 | [
"Q05084"
] | 7 | 8113184-8262687 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA017646",
"HPA061452"
] | [
"ICA69",
"ICAp69"
] | [
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Neurotransmitter transport",
"Transport"
] | [] | [] | [
"Vesicles",
"Cytosol"
] | [] | [] | [] | Supported | Approved | null | 8 | null | null | Cluster 9: T-regs - Cell cycle regulation | Cluster 34: Non-specific - Mixed function | Cluster 17: Neuroblastoma - Neuronal signaling | Cluster 37: Neutrophil progenitors - Granulopoiesis | Cluster 8: Pancreas - Proteolysis | Low tissue specificity | Detected in all | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enriched | Detected in many | 6 | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 34 | 4 |
ENSG00000003393 | ALS2 | Alsin Rho guanine nucleotide exchange factor ALS2 | [
"Q96Q42"
] | 2 | 201700267-201782112 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA046588",
"HPA075409"
] | [
"ALS2CR6"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [] | [
"Guanine-nucleotide releasing factor"
] | [
"Amyotrophic lateral sclerosis",
"Neurodegeneration"
] | [
"Vesicles",
"Cytosol"
] | [] | [] | [] | Approved | Enhanced | null | 20 | null | null | Cluster 46: Basophils - Proteolysis | Cluster 35: Non-specific - DNA binding | Cluster 49: HMC-1 - Innate immune response | Cluster 2: Cerebellar granular cells - Neuronal signaling | Cluster 27: Cerebellum - Synaptic function | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Group enriched | Detected in many | 5 | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Renal Papillary Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 36 | 5 |
ENSG00000003400 | CASP10 | Caspase 10 | [
"Q92851"
] | 2 | 201182872-201229428 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB003780",
"HPA017059"
] | [
"FLICE-2",
"MCH4"
] | [
"Cancer-related genes",
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Potential drug targets",
"Predicted intracellular proteins"
] | [
"Apoptosis"
] | [
"Hydrolase",
"Protease",
"Thiol protease"
] | [
"Cancer-related genes",
"Disease variant"
] | [
"Golgi apparatus"
] | [
"Vesicles"
] | [] | [] | Approved | Approved | null | 21 | null | null | Cluster 2: Dendritic cells - Unknown function | Cluster 47: Endothelial cells - Vasculature | Cluster 51: Myeloma - Immunoglobulins | Cluster 37: Neutrophil progenitors - Granulopoiesis | Cluster 5: Spleen - Immune response | Low tissue specificity | Detected in all | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 1 | 0 | 1 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 37 | 8 |
ENSG00000003402 | CFLAR | CASP8 and FADD like apoptosis regulator | [
"O15519"
] | 2 | 201116154-201176687 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA019044",
"CAB022157",
"CAB025216"
] | [
"c-FLIP",
"CASH",
"CASP8AP1",
"Casper",
"cFLIP",
"CLARP",
"FLAME",
"FLIP",
"I-FLICE",
"MRIT"
] | [
"Cancer-related genes",
"Enzymes",
"Predicted intracellular proteins"
] | [
"Apoptosis",
"Host-virus interaction"
] | [] | [
"Cancer-related genes"
] | [
"Nucleoplasm",
"Plasma membrane",
"Cytosol"
] | [
"Nuclear bodies"
] | [] | [] | Supported | Uncertain | null | 34 | null | Yes | Cluster 35: Neutrophils - Protein binding | Cluster 25: Non-specific - Transcription | Cluster 55: Lymphoma - Immune response | Cluster 24: Neutrophils - Innate immunity signal integration | Cluster 14: Adipose tissue - Angiogenesis | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Immune cell enriched | Detected in all | 4 | 2 | 0 | 2 | [
"Breast Invasive Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Breast Invasive Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | 38 | 1 |
ENSG00000003509 | NDUFAF7 | NADH:ubiquinone oxidoreductase complex assembly factor 7 | [
"Q7L592"
] | 2 | 37231631-37253403 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA045217"
] | [
"C2orf56",
"MidA",
"PRO1853"
] | [
"Disease related genes",
"Enzymes",
"Potential drug targets",
"Predicted intracellular proteins"
] | [] | [
"Methyltransferase",
"Transferase"
] | [] | [] | [] | [] | [] | null | Uncertain | null | 8 | null | null | Cluster 30: Non-specific - DNA binding | Cluster 52: Neurons & Synapses - Synaptic function | Cluster 26: Non-specific - Mitochondria & RNA binding | Cluster 53: Late primary spermatocytes - Meiotic division & transition | Cluster 39: Testis - Nuclear processes | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 40 | 4 |
ENSG00000003756 | RBM5 | RNA binding motif protein 5 | [
"P52756"
] | 3 | 50088919-50119021 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA017335",
"HPA018011"
] | [
"H37",
"LUCA-15",
"LUCA15"
] | [
"Predicted intracellular proteins"
] | [
"Apoptosis",
"mRNA processing",
"mRNA splicing"
] | [
"RNA-binding"
] | [] | [
"Nucleoplasm"
] | [
"Perinuclear theca",
"Flagellar centriole",
"Mid piece",
"Principal piece",
"End piece"
] | [] | [] | Supported | Approved | null | 34 | null | null | Cluster 35: Neutrophils - Protein binding | Cluster 28: Oligodendrocytes - Mixed function | Cluster 8: Non-specific - Basic cellular processes | Cluster 7: Non-specific - Transcription | Cluster 64: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Glioblastoma Multiforme",
"Kidney Renal Papillary Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | [] | [
"Glioblastoma Multiforme",
"Kidney Renal Papillary Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 41 | 5 |
ENSG00000003987 | MTMR7 | Myotubularin related protein 7 | [
"Q9Y216"
] | 8 | 17296794-17413528 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA075682"
] | [] | [
"Enzymes",
"Metabolic proteins",
"Predicted intracellular proteins"
] | [
"Lipid metabolism"
] | [
"Hydrolase"
] | [] | [
"Nucleoplasm",
"Cytosol"
] | [] | [] | [] | Approved | null | null | 13 | null | null | null | Cluster 34: Non-specific - Mixed function | Cluster 71: Lymphoma - Inflammatory response | Cluster 79: Photoreceptor cells - Phototransduction | Cluster 46: Brain & retina - Neuronal signaling | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 2 | 0 | 2 | [
"Glioblastoma Multiforme",
"Pancreatic Adenocarcinoma"
] | [] | [
"Glioblastoma Multiforme",
"Pancreatic Adenocarcinoma"
] | 42 | 4 |
ENSG00000003989 | SLC7A2 | Solute carrier family 7 member 2 | [
"P52569"
] | 8 | 17497088-17570573 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA009277"
] | [
"ATRC2",
"CAT-2",
"HCAT2"
] | [
"Metabolic proteins",
"Predicted membrane proteins",
"Transporters"
] | [
"Amino-acid transport",
"Transport"
] | [] | [] | [
"Plasma membrane"
] | [
"Cell Junctions"
] | [] | [] | Supported | null | null | 5 | null | null | null | Cluster 8: Immune cells - Immune response | Cluster 10: Ciliated cells - Ion channel activity | Cluster 51: Secretory epithelial cells - Mixed function | Cluster 76: Non-specific - Metabolism | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [] | [
"Stomach Adenocarcinoma"
] | [
"Stomach Adenocarcinoma"
] | 43 | 7 |
ENSG00000004059 | ARF5 | ADP ribosylation factor 5 | [
"P84085"
] | 7 | 127588386-127591700 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [] | [
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"ER-Golgi transport",
"Protein transport",
"Transport"
] | [] | [] | [] | [] | [] | [] | null | null | null | 33 | null | null | Cluster 26: Monocytes - Plasma membrane proteins | Cluster 14: Neurons - Synaptic function | Cluster 39: Non-specific - Transcription | Cluster 97: Non-specific - Cellular respiration | Cluster 68: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 44 | 8 |
ENSG00000004139 | SARM1 | Sterile alpha and TIR motif containing 1 | [
"Q6SZW1"
] | 17 | 28364356-28404049 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA024359",
"HPA024759"
] | [
"KIAA0524",
"SAMD2",
"SARM"
] | [
"Enzymes",
"Predicted intracellular proteins"
] | [
"Differentiation",
"Immunity",
"Innate immunity",
"Neurogenesis"
] | [
"Hydrolase"
] | [] | [
"Mitochondria"
] | [] | [] | [] | Supported | Uncertain | null | 9 | null | null | null | Cluster 15: Non-specific - Transcription | Cluster 72: Neuronal - Signal transduction | Cluster 72: Macrophages - Phagocytosis & lysosomal degradation | Cluster 64: Non-specific - Transcription | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 45 | 5 |
ENSG00000004142 | POLDIP2 | DNA polymerase delta interacting protein 2 | [
"Q9Y2S7"
] | 17 | 28346633-28357527 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA007700"
] | [
"DKFZP586F1524",
"PDIP38"
] | [
"Essential proteins",
"Predicted intracellular proteins"
] | [
"DNA damage",
"DNA repair"
] | [] | [] | [
"Mitochondria"
] | [] | [] | [] | Approved | null | null | 32 | null | null | Cluster 25: Non-specific - Unknown function | Cluster 32: Cerebral cortex - Mixed function | Cluster 27: Breast cancer - Unknown function | Cluster 23: Elongating spermatids - Sperm cell metabolism & fertilization | Cluster 25: Non-specific - Basic cellular processes | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Liver Hepatocellular Carcinoma"
] | 46 | 8 |
ENSG00000004455 | AK2 | Adenylate kinase 2 | [
"P54819"
] | 1 | 33007986-33080996 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA018479",
"CAB079913"
] | [] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Metabolic proteins",
"Plasma proteins",
"Potential drug targets",
"Predicted intracellular proteins"
] | [] | [
"Kinase",
"Transferase"
] | [
"Disease variant",
"SCID"
] | [
"Mitochondria"
] | [] | [] | [] | Approved | Approved | null | 16 | null | null | Cluster 29: Non-specific - Unknown function | Cluster 6: Non-specific - Immune response | Cluster 37: Non-specific - mRNA processing | Cluster 97: Non-specific - Cellular respiration | Cluster 76: Non-specific - Metabolism | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 4 | 0 | 4 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Chromophobe",
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | 48 | 5 |
ENSG00000004468 | CD38 | CD38 molecule | [
"P28907"
] | 4 | 15778275-15853232 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB002493",
"HPA022132",
"CAB025255",
"HPA052381"
] | [
"cADPR1"
] | [
"Cancer-related genes",
"CD markers",
"Enzymes",
"Metabolic proteins",
"Predicted intracellular proteins"
] | [] | [
"Hydrolase",
"Receptor",
"Transferase"
] | [
"Cancer-related genes",
"Diabetes mellitus"
] | [
"Plasma membrane"
] | [] | [] | [] | Supported | Enhanced | null | 3 | null | null | Cluster 14: Non-specific - Unknown function | Cluster 46: Brainstem - Mixed function | Cluster 46: Lymphoma - Humoral immune response | Cluster 44: Plasma cells - Antibody production & secretion | Cluster 51: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in many | null | Group enriched | Detected in some | 15 | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in many | null | 2 | 0 | 2 | [
"Head and Neck Squamous Cell Carcinoma",
"Ovary Serous Cystadenocarcinoma"
] | [] | [
"Head and Neck Squamous Cell Carcinoma",
"Ovary Serous Cystadenocarcinoma"
] | 49 | 7 |
ENSG00000004478 | FKBP4 | FKBP prolyl isomerase 4 | [
"Q02790"
] | 12 | 2794970-2805423 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA006148",
"CAB017441",
"HPA062857"
] | [
"FKBP52",
"FKBP59"
] | [
"Enzymes",
"Metabolic proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [] | [
"Chaperone",
"Isomerase",
"Rotamase"
] | [] | [
"Cytosol"
] | [
"Nucleoplasm"
] | [] | [] | Supported | Supported | null | 57 | null | null | Cluster 43: Non-specific - Transcription & Translation | Cluster 55: Non-specific - Transcription | Cluster 27: Breast cancer - Unknown function | Cluster 75: Non-specific - Chaperones and protein folding | Cluster 67: Testis - Mixed function | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 2 | 1 | [] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | 50 | 2 |
ENSG00000004534 | RBM6 | RNA binding motif protein 6 | [
"P78332"
] | 3 | 49940007-50100045 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA026272",
"HPA027164"
] | [
"3G2",
"DEF-3",
"DEF3",
"g16",
"NY-LU-12"
] | [
"Cancer-related genes",
"Plasma proteins",
"Predicted intracellular proteins"
] | [] | [
"RNA-binding"
] | [
"Cancer-related genes"
] | [
"Nuclear speckles"
] | [
"Cytoplasmic bodies"
] | [] | [] | Approved | Enhanced | null | 37 | null | null | Cluster 5: Non-specific - Cell proliferation | Cluster 4: Non-specific - mRNA splicing & Cell cycle | Cluster 8: Non-specific - Basic cellular processes | Cluster 87: B-cells - Adaptive immunity: Humoral response | Cluster 64: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 52 | 4 |
ENSG00000004700 | RECQL | RecQ like helicase | [
"P46063"
] | 12 | 21468910-21501669 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB009743",
"HPA030960",
"HPA030961",
"HPA064259",
"CAB080253"
] | [
"RecQ1",
"RecQL1"
] | [
"Enzymes",
"Plasma proteins",
"Predicted intracellular proteins"
] | [] | [
"DNA-binding",
"Helicase",
"Hydrolase",
"Isomerase"
] | [
"Disease variant"
] | [
"Nucleoplasm"
] | [] | [] | [] | Supported | Enhanced | null | 21 | null | null | Cluster 33: Non-specific - ATP binding | Cluster 28: Oligodendrocytes - Mixed function | Cluster 38: Non-specific - Transcription | Cluster 17: Non-specific - RNA processing | Cluster 66: Lymphoid tissue - Immune response | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Lung Adenocarcinoma"
] | [
"Lung Adenocarcinoma"
] | 54 | 9 |
ENSG00000004766 | VPS50 | VPS50 subunit of EARP/GARPII complex | [
"Q96JG6"
] | 7 | 93232340-93361123 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA026679"
] | [
"CCDC132",
"DKFZp313I2429",
"FLJ20097",
"KIAA1861",
"VPS54L"
] | [
"Disease related genes",
"Predicted intracellular proteins"
] | [
"Protein transport",
"Transport"
] | [] | [
"Epilepsy",
"Intellectual disability",
"Intrahepatic cholestasis"
] | [
"Plasma membrane",
"Cytosol"
] | [
"Primary cilium",
"Basal body",
"Mid piece",
"Principal piece",
"End piece"
] | [] | [] | Uncertain | Approved | null | 18 | null | null | Cluster 33: Non-specific - ATP binding | Cluster 31: Non-specific - Transcription | Cluster 39: Non-specific - Transcription | Cluster 7: Non-specific - Transcription | Cluster 38: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [] | [
"Colon Adenocarcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Colon Adenocarcinoma",
"Liver Hepatocellular Carcinoma"
] | 55 | 9 |
ENSG00000004776 | HSPB6 | Heat shock protein family B (small) member 6 | [
"O14558"
] | 19 | 35754566-35758079 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB001974",
"HPA044153",
"HPA054811"
] | [
"FLJ32389",
"Hsp20",
"PPP1R91"
] | [
"Predicted intracellular proteins"
] | [
"Stress response"
] | [
"Chaperone"
] | [] | [
"Mitochondria",
"Cytosol"
] | [
"Nuclear speckles"
] | [
"Intracellular and membrane"
] | [
"Other"
] | Supported | Enhanced | null | 4 | null | null | null | Cluster 19: Astrocytes - Mixed function | Cluster 44: Connective tissue cells - ECM organization | Cluster 62: Smooth muscle cells - Muscle contraction | Cluster 25: Non-specific - Basic cellular processes | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Cancer enhanced | Detected in all | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 56 | 2 |
ENSG00000004777 | ARHGAP33 | Rho GTPase activating protein 33 | [
"O14559"
] | 19 | 35774532-35788822 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA030117",
"HPA030118"
] | [
"FLJ39019",
"SNX26",
"TCGAP"
] | [
"Predicted intracellular proteins"
] | [
"Protein transport",
"Transport"
] | [
"GTPase activation"
] | [] | [
"Plasma membrane"
] | [
"Actin filaments",
"Cytosol"
] | [] | [] | Approved | Supported | null | 2 | null | null | null | Cluster 51: Neurons - Mixed function | Cluster 10: Ciliated cells - Ion channel activity | Cluster 27: Non-specific - Cell proliferation | Cluster 67: Testis - Mixed function | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cancer enhanced | Detected in all | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma"
] | 57 | 6 |
ENSG00000004779 | NDUFAB1 | NADH:ubiquinone oxidoreductase subunit AB1 | [
"O14561"
] | 16 | 23581014-23596316 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA054364",
"HPA076020"
] | [
"ACP",
"ACP1",
"FASN2A",
"SDAP"
] | [
"Essential proteins",
"Metabolic proteins",
"Predicted intracellular proteins"
] | [
"Electron transport",
"Fatty acid biosynthesis",
"Fatty acid metabolism",
"Lipid biosynthesis",
"Lipid metabolism",
"Respiratory chain",
"Transport"
] | [] | [] | [
"Mitochondria"
] | [] | [] | [] | Supported | Approved | null | 60 | No | No | Cluster 13: Non-specific - Mitochondria | Cluster 21: Non-specific - Metabolism | Cluster 54: Non-specific - Transcription | Cluster 97: Non-specific - Cellular respiration | Cluster 52: Non-specific - Cellular respiration | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Breast Invasive Carcinoma"
] | [
"Breast Invasive Carcinoma"
] | 58 | 7 |
ENSG00000004799 | PDK4 | Pyruvate dehydrogenase kinase 4 | [
"Q16654"
] | 7 | 95583499-95596516 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA056731"
] | [] | [
"Enzymes",
"Metabolic proteins",
"Predicted intracellular proteins"
] | [] | [
"Kinase",
"Transferase"
] | [] | [] | [] | [] | [] | null | Approved | null | 2 | null | null | Cluster 25: Non-specific - Unknown function | Cluster 36: Choroid plexus - Mixed function | Cluster 44: Connective tissue cells - ECM organization | Cluster 103: Non-specific - Basic cellular processes | Cluster 63: Non-specific - Basic cellular processes | Tissue enhanced | Detected in all | null | Cancer enhanced | Detected in many | null | Group enriched | Detected in all | 4 | Cell type enhanced | Detected in many | null | Group enriched | Detected in many | 11 | 5 | 2 | 4 | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Papillary Cell Carcinoma",
"Stomach Adenocarcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Stomach Adenocarcinoma"
] | 59 | 2 |
ENSG00000004809 | SLC22A16 | Solute carrier family 22 member 16 | [
"Q86VW1"
] | 6 | 110424687-110476641 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA036902"
] | [
"CT2",
"FLIPT2",
"OAT6",
"OKB1"
] | [
"Metabolic proteins",
"Predicted membrane proteins",
"Transporters"
] | [
"Differentiation",
"Ion transport",
"Spermatogenesis",
"Transport"
] | [
"Developmental protein"
] | [] | [
"Plasma membrane",
"Cytosol"
] | [] | [] | [] | Approved | Uncertain | null | 2 | null | null | Cluster 26: Monocytes - Plasma membrane proteins | null | Cluster 14: Myeloid leukemia - Innate immune response | Cluster 66: Erythroid cells - Erythroid differentiation and maturation | Cluster 44: Bone marrow - Nuclear processes | Group enriched | Detected in some | 5 | Cancer enriched | Detected in single | 11 | Cancer enriched | Detected in single | 7 | Cell type enhanced | Detected in some | null | Immune cell enhanced | Detected in some | null | 0 | 0 | 0 | [] | [] | [] | 60 | 6 |
ENSG00000004838 | ZMYND10 | Zinc finger MYND-type containing 10 | [
"O75800"
] | 3 | 50341110-50345732 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA035255"
] | [
"BLU",
"CILD22",
"DNAAF7"
] | [
"Disease related genes",
"Human disease related genes",
"Plasma proteins",
"Predicted intracellular proteins"
] | [] | [] | [
"Ciliopathy",
"Disease variant",
"Kartagener syndrome",
"Primary ciliary dyskinesia"
] | [
"Plasma membrane",
"Basal body"
] | [
"Cytosol"
] | [] | [] | Approved | null | null | 12 | null | null | null | Cluster 3: Choroid plexus - Cilium | Cluster 10: Ciliated cells - Ion channel activity | Cluster 107: Ciliated cells - Cilia assembly & function | Cluster 56: Ciliated tissues - Cilium organization | Group enriched | Detected in many | 13 | Low cancer specificity | Detected in many | null | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in single | null | 2 | 0 | 2 | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | [] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | 61 | 1 |
ENSG00000004846 | ABCB5 | ATP binding cassette subfamily B member 5 | [
"Q2M3G0"
] | 7 | 20615667-20777038 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"ABCB5alpha",
"ABCB5beta",
"EST422562"
] | [
"Enzymes",
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Transporters"
] | [
"Differentiation",
"Transport"
] | [
"Translocase"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | null | Cluster 48: Non-specific - Mixed function | Cluster 9: Skin cancer - Melanin biosynthesis | Cluster 30: Epididymal principal cells - Sperm storage microenvironment | Cluster 50: Epididymis - Male reproductive secretion | Tissue enriched | Detected in some | 10 | Cancer enriched | Detected in some | 13 | Group enriched | Detected in some | 13 | Group enriched | Detected in many | 4 | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma"
] | 62 | 4 |
ENSG00000004848 | ARX | Aristaless related homeobox | [
"Q96QS3"
] | X | 25003694-25016420 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"CT121",
"EIEE1",
"ISSX",
"MRX29",
"MRX32",
"MRX33",
"MRX36",
"MRX38",
"MRX43",
"MRX54",
"MRX76",
"MRX87",
"MRXS1",
"PRTS"
] | [
"Disease related genes",
"Human disease related genes",
"Plasma proteins",
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Differentiation",
"Neurogenesis",
"Transcription",
"Transcription regulation"
] | [
"Developmental protein",
"DNA-binding"
] | [
"Disease variant",
"Epilepsy",
"Intellectual disability",
"Lissencephaly"
] | [] | [] | [] | [] | null | null | null | 7 | null | null | null | Cluster 53: Neurons - Mixed function | Cluster 12: Bone cancer - Neuronal signaling | Cluster 94: Gonadal somatic cells - Mixed function | Cluster 75: Ovary - Mixed function | Group enriched | Detected in some | 5 | Cancer enriched | Detected in some | 6 | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 2 | 0 | 2 | [] | [
"Glioblastoma Multiforme",
"Uterine Corpus Endometrial Carcinoma"
] | [
"Glioblastoma Multiforme",
"Uterine Corpus Endometrial Carcinoma"
] | 63 | 1 |
ENSG00000004864 | SLC25A13 | Solute carrier family 25 member 13 | [
"Q9UJS0"
] | 7 | 96120220-96322147 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA018997"
] | [
"ARALAR2",
"CITRIN",
"CTLN2"
] | [
"Disease related genes",
"Human disease related genes",
"Metabolic proteins",
"Plasma proteins",
"Potential drug targets",
"Predicted intracellular proteins",
"Transporters"
] | [
"Transport"
] | [] | [
"Disease variant",
"Intrahepatic cholestasis"
] | [
"Mitochondria"
] | [] | [] | [] | Supported | Enhanced | null | 31 | null | null | Cluster 25: Non-specific - Unknown function | Cluster 28: Oligodendrocytes - Mixed function | Cluster 39: Non-specific - Transcription | Cluster 31: Neutrophils - Chemotaxis & Apoptosis | Cluster 16: Liver & Kidney - Metabolism | Tissue enriched | Detected in all | 5 | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 64 | 2 |
ENSG00000004866 | ST7 | Suppression of tumorigenicity 7 | [
"Q9NRC1"
] | 7 | 116953238-117230176 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA038325",
"HPA038326"
] | [
"ETS7q",
"FAM4A",
"FAM4A1",
"HELG",
"RAY1",
"SEN4",
"TSG7"
] | [
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [] | [] | [
"Nucleoplasm"
] | [
"Cytosol"
] | [] | [] | Supported | Approved | null | 26 | No | No | Cluster 5: Non-specific - Cell proliferation | Cluster 35: Non-specific - DNA binding | Cluster 39: Non-specific - Transcription | Cluster 88: Proximal tubular cells - Transmembrane transport | Cluster 22: Epididymis - Mixed function | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 2 | 0 | 2 | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | 65 | 4 |
ENSG00000004897 | CDC27 | Cell division cycle 27 | [
"P30260"
] | 17 | 47117703-47189422 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB016315",
"HPA028129",
"HPA052399",
"HPA065835"
] | [
"ANAPC3",
"APC3",
"D0S1430E",
"D17S978E",
"NUC2"
] | [
"Cancer-related genes",
"Essential proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Ubl conjugation pathway"
] | [] | [
"Cancer-related genes"
] | [
"Nucleoplasm"
] | [] | [] | [] | Enhanced | Supported | null | 114 | null | Yes | Cluster 5: Non-specific - Cell proliferation | Cluster 31: Non-specific - Transcription | Cluster 27: Breast cancer - Unknown function | Cluster 103: Non-specific - Basic cellular processes | Cluster 61: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 4 | 2 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Ovary Serous Cystadenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Ovary Serous Cystadenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 66 | 6 |
ENSG00000004939 | SLC4A1 | Solute carrier family 4 member 1 (Diego blood group) | [
"P02730"
] | 17 | 44248390-44268141 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA015584",
"CAB034438",
"HPA063911"
] | [
"AE1",
"CD233",
"DI",
"EPB3",
"FR",
"RTA1A",
"SW",
"WD",
"WR"
] | [
"Blood group antigen proteins",
"CD markers",
"Disease related genes",
"Human disease related genes",
"Metabolic proteins",
"Plasma proteins",
"Potential drug targets",
"Predicted membrane proteins",
"Transporters"
] | [
"Anion exchange",
"Ion transport",
"Transport"
] | [
"Blood group antigen"
] | [
"Disease variant",
"Elliptocytosis",
"Hereditary hemolytic anemia"
] | [] | [] | [] | [] | null | Enhanced | null | 15 | null | null | null | Cluster 48: Non-specific - Mixed function | Cluster 47: Leukemia - Hemostasis | Cluster 66: Erythroid cells - Erythroid differentiation and maturation | Cluster 15: Bone marrow - Innate immune response | Tissue enriched | Detected in some | 10 | Cancer enriched | Detected in single | 62 | Cancer enriched | Detected in many | 56 | Group enriched | Detected in some | 38 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 67 | 2 |
ENSG00000004948 | CALCR | Calcitonin receptor | [] | 7 | 93424486-93574730 | Evidence at protein level | Evidence at protein level | null | null | [
"HPA028962",
"HPA061428"
] | [
"CT-R",
"CTR"
] | [
"Human disease related genes",
"Predicted membrane proteins"
] | [] | [] | [] | [
"Cell Junctions"
] | [
"Vesicles",
"Centriolar satellite"
] | [] | [] | Approved | Enhanced | Supported | 2 | null | null | null | Cluster 56: Hypothalamus - Neuropeptide signaling | Cluster 15: Kidney cancer - Membrane components | Cluster 50: Renal epithelial cells - Ion transport and pH regulation | Cluster 72: Kidney - Transmembrane transport | Tissue enhanced | Detected in some | null | Cancer enhanced | Detected in some | null | Group enriched | Detected in some | 5 | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 68 | 1 |
ENSG00000004961 | HCCS | Holocytochrome c synthase | [
"P53701"
] | X | 11111301-11123086 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA002946"
] | [
"CCHL",
"MLS"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Metabolic proteins",
"Potential drug targets",
"Predicted intracellular proteins"
] | [] | [
"Lyase"
] | [
"Disease variant",
"Microphthalmia"
] | [
"Mitochondria"
] | [
"Cytosol"
] | [] | [] | Enhanced | Approved | null | 22 | null | null | Cluster 10: Non-specific - Membrane trafficking | Cluster 23: Choroid plexus - Mixed function | Cluster 36: Non-specific - mRNA processing | Cluster 17: Non-specific - RNA processing | Cluster 52: Non-specific - Cellular respiration | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 69 | 2 |
ENSG00000004975 | DVL2 | Dishevelled segment polarity protein 2 | [
"O14641"
] | 17 | 7225342-7234517 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA021611",
"HPA022914",
"HPA064732"
] | [] | [
"Predicted intracellular proteins"
] | [
"Wnt signaling pathway"
] | [
"Developmental protein"
] | [] | [
"Nucleoplasm",
"Nuclear bodies"
] | [
"Aggresome"
] | [] | [] | Approved | Approved | null | 146 | null | null | Cluster 3: Non-specific - Nuclear processes | Cluster 11: White matter - Signal transduction | Cluster 42: Non-specific - Unknown function | Cluster 39: Syncytiotrophoblasts - Placental homeostasis & endocrine signal | Cluster 64: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 70 | 4 |
ENSG00000005001 | PRSS22 | Serine protease 22 | [
"Q9GZN4"
] | 16 | 2852730-2858170 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA049161"
] | [
"BSSP-4",
"hBSSP-4",
"SP001LA"
] | [
"Enzymes",
"Predicted secreted proteins"
] | [] | [
"Hydrolase",
"Protease",
"Serine protease"
] | [] | [] | [] | [
"Secreted in other tissues"
] | [
"Enzyme"
] | null | Approved | null | 11 | null | null | null | null | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 49: Apical squamous epithelium - Epithelial barrier & keratinization | Cluster 81: Squamous epithelium - Keratinization | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [
"Thyroid Carcinoma"
] | [] | [
"Thyroid Carcinoma"
] | 71 | 1 |
ENSG00000005007 | UPF1 | UPF1 RNA helicase and ATPase | [
"Q92900"
] | 19 | 18831959-18868230 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA019587",
"HPA020857"
] | [
"HUPF1",
"KIAA0221",
"NORF1",
"pNORF1",
"RENT1",
"smg-2"
] | [
"Enzymes",
"Essential proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Host-virus interaction",
"Nonsense-mediated mRNA decay"
] | [
"Helicase",
"Hydrolase",
"RNA-binding"
] | [] | [
"Nucleoplasm"
] | [
"Cytosol"
] | [] | [] | Supported | Approved | null | 191 | null | null | null | Cluster 27: Non-specific - Mixed function | Cluster 23: Non-specific - Transcription | Cluster 24: Neutrophils - Innate immunity signal integration | Cluster 24: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Not detected in immune cells | Not detected | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Skin Cutaneous Melanoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Skin Cutaneous Melanoma"
] | 72 | 8 |
ENSG00000005020 | SKAP2 | Src kinase associated phosphoprotein 2 | [
"O75563"
] | 7 | 26667068-26995239 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA005560",
"HPA024045"
] | [
"RA70",
"SAPS",
"SCAP2",
"SKAP-HOM",
"SKAP55R"
] | [
"Predicted intracellular proteins"
] | [
"B-cell activation"
] | [] | [] | [
"Nucleoplasm"
] | [
"Cytosol"
] | [] | [] | Supported | Enhanced | null | 12 | null | null | Cluster 2: Dendritic cells - Unknown function | Cluster 22: Non-specific - Mixed function | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 48: Neutrophils - Phagocytosis & degranulation | Cluster 66: Lymphoid tissue - Immune response | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 4 | 0 | 4 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Chromophobe",
"Liver Hepatocellular Carcinoma",
"Lung Squamous Cell Carcinoma"
] | [
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Squamous Cell Carcinoma"
] | 73 | 1 |
ENSG00000005022 | SLC25A5 | Solute carrier family 25 member 5 | [
"P05141"
] | X | 119468422-119471396 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA046835",
"HPA071684"
] | [
"2F1",
"ANT2",
"T2",
"T3"
] | [
"Essential proteins",
"FDA approved drug targets",
"Metabolic proteins",
"Plasma proteins",
"Predicted membrane proteins",
"Transporters"
] | [
"Antiport",
"Chromosome partition",
"Host-virus interaction",
"Transport"
] | [] | [
"FDA approved drug targets"
] | [
"Mitochondria"
] | [] | [] | [] | Supported | Approved | null | 42 | null | null | Cluster 33: Non-specific - ATP binding | Cluster 45: Non-specific - Mixed function | Cluster 36: Non-specific - mRNA processing | Cluster 45: Colonocytes & Enterocytes - Gastrointestinal absorption & barrier | Cluster 60: Stomach - Digestion | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 4 | 0 | 4 | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 74 | 6 |
ENSG00000005059 | MCUB | Mitochondrial calcium uniporter dominant negative subunit beta | [
"Q9NWR8"
] | 4 | 109560209-109688719 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA014058",
"HPA048776"
] | [
"CCDC109B",
"FLJ20647"
] | [
"Predicted membrane proteins",
"Transporters"
] | [
"Calcium transport",
"Ion transport",
"Transport"
] | [] | [] | [
"Mitochondria"
] | [
"Cytosol"
] | [] | [] | Supported | Enhanced | null | 3 | null | null | Cluster 33: Non-specific - ATP binding | Cluster 39: Astrocytes - Mixed function | Cluster 46: Lymphoma - Humoral immune response | Cluster 9: T-cells - Adaptive immunity: Regulation | Cluster 51: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 2 | 0 | 2 | [] | [
"Glioblastoma Multiforme",
"Lung Squamous Cell Carcinoma"
] | [
"Glioblastoma Multiforme",
"Lung Squamous Cell Carcinoma"
] | 75 | 3 |
ENSG00000005073 | HOXA11 | Homeobox A11 | [
"P31270"
] | 7 | 27181157-27185232 | Evidence at protein level | Evidence at protein level | Evidence at transcript level | Evidence at protein level | [
"HPA006770",
"HPA035623"
] | [
"HOX1",
"HOX1I"
] | [
"Cancer-related genes",
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Transcription",
"Transcription regulation"
] | [
"Developmental protein",
"DNA-binding"
] | [
"Cancer-related genes"
] | [
"Nucleoplasm"
] | [] | [] | [] | Supported | Enhanced | null | 3 | null | null | null | null | Cluster 32: Non-specific - Cell proliferation | Cluster 108: Fibroblasts - ECM organization | Cluster 75: Ovary - Mixed function | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 3 | 0 | 3 | [] | [
"Kidney Chromophobe",
"Rectum Adenocarcinoma",
"Skin Cutaneous Melanoma"
] | [
"Kidney Chromophobe",
"Rectum Adenocarcinoma",
"Skin Cutaneous Melanoma"
] | 76 | 4 |
ENSG00000005075 | POLR2J | RNA polymerase II subunit J | [
"P52435"
] | 7 | 102473128-102478922 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA046970"
] | [
"hRPB14",
"POLR2J1",
"RPB11",
"RPB11A",
"RPB11m"
] | [
"Metabolic proteins",
"Predicted intracellular proteins",
"RNA polymerase related proteins"
] | [
"Transcription"
] | [] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Approved | null | null | 147 | null | null | Cluster 36: Eosinophils - Protein ubiquitination | Cluster 44: Non-specific - Mixed function | Cluster 39: Non-specific - Transcription | Cluster 97: Non-specific - Cellular respiration | Cluster 25: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 2 | 2 | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 77 | 4 |
ENSG00000005100 | DHX33 | DEAH-box helicase 33 | [
"Q9H6R0"
] | 17 | 5440917-5468982 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA071536",
"HPA073875"
] | [
"DDX33",
"DKFZp762F2011",
"FLJ21972"
] | [
"Enzymes",
"Essential proteins",
"Predicted intracellular proteins"
] | [] | [
"Helicase",
"Hydrolase"
] | [] | [
"Nucleoli"
] | [] | [] | [] | Enhanced | Supported | null | 12 | null | null | Cluster 12: Non-specific - Mitochondrial translation | Cluster 40: Astrocytes - Astrocyte-neuron interactions | Cluster 42: Non-specific - Unknown function | Cluster 17: Non-specific - RNA processing | Cluster 63: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 78 | 2 |
ENSG00000005102 | MEOX1 | Mesenchyme homeobox 1 | [
"P50221"
] | 17 | 43640389-43661922 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA045214",
"HPA063788"
] | [
"MOX1"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Transcription",
"Transcription regulation"
] | [
"Activator",
"Developmental protein",
"DNA-binding",
"Repressor"
] | [] | [
"Nucleoplasm"
] | [
"Cytokinetic bridge",
"Cytosol"
] | [] | [] | Approved | Uncertain | null | 81 | Yes | null | Cluster 9: T-regs - Cell cycle regulation | Cluster 53: Neurons - Mixed function | Cluster 15: Kidney cancer - Membrane components | Cluster 32: Endothelial cells - Angiogenesis & vascular immunity | Cluster 14: Adipose tissue - Angiogenesis | Tissue enhanced | Detected in many | null | Group enriched | Detected in many | 6 | Cancer enhanced | Detected in many | null | Cell type enriched | Detected in some | 9 | Immune cell enriched | Detected in some | 4 | 0 | 0 | 0 | [] | [] | [] | 79 | 1 |
ENSG00000005108 | THSD7A | Thrombospondin type 1 domain containing 7A | [
"Q9UPZ6"
] | 7 | 11370365-11832198 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA000923"
] | [
"KIAA0960"
] | [
"Disease related genes",
"Predicted membrane proteins",
"Predicted secreted proteins"
] | [
"Angiogenesis",
"Differentiation"
] | [] | [] | [] | [] | [
"Secreted to blood"
] | [
"Developmental protein"
] | null | Supported | null | 13 | null | null | Cluster 46: Basophils - Proteolysis | Cluster 19: Astrocytes - Mixed function | Cluster 17: Neuroblastoma - Neuronal signaling | Cluster 57: Podocytes - Glomerular filtration | Cluster 72: Kidney - Transmembrane transport | Tissue enhanced | Detected in many | null | Cancer enriched | Detected in many | 6 | Cancer enriched | Detected in many | 6 | Cell type enhanced | Detected in many | null | Immune cell enriched | Detected in single | 53 | 2 | 2 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 80 | 5 |
ENSG00000005156 | LIG3 | DNA ligase 3 | [
"P49916"
] | 17 | 34980512-35009743 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA006723",
"CAB080348"
] | [
"LIG2",
"LIG3alpha"
] | [
"Disease related genes",
"Enzymes",
"Essential proteins",
"Human disease related genes",
"Plasma proteins",
"Potential drug targets",
"Predicted intracellular proteins"
] | [
"Cell cycle",
"Cell division",
"DNA damage",
"DNA recombination",
"DNA repair",
"DNA replication"
] | [
"Ligase"
] | [
"Disease variant",
"Primary mitochondrial disease"
] | [
"Nucleoplasm"
] | [] | [] | [] | Supported | Supported | null | 48 | null | null | Cluster 30: Non-specific - DNA binding | Cluster 16: Non-specific - Transcription | Cluster 27: Breast cancer - Unknown function | Cluster 83: Epicardial mesothelial cells - Basic cellular functions | Cluster 39: Testis - Nuclear processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 4 | 0 | 4 | [
"Kidney Renal Clear Cell Carcinoma",
"Rectum Adenocarcinoma"
] | [
"Colon Adenocarcinoma",
"Skin Cutaneous Melanoma"
] | [
"Colon Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Rectum Adenocarcinoma",
"Skin Cutaneous Melanoma"
] | 81 | 5 |
ENSG00000005175 | RPAP3 | RNA polymerase II associated protein 3 | [
"Q9H6T3"
] | 12 | 47661249-47706030 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA038311",
"HPA038312"
] | [
"FLJ21908",
"hSpagh",
"spag",
"Tah1"
] | [
"Essential proteins",
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Cytosol"
] | [
"Primary cilium",
"Primary cilium tip",
"Basal body",
"Acrosome"
] | [] | [] | Enhanced | Enhanced | null | 102 | null | null | Cluster 14: Non-specific - Unknown function | Cluster 31: Non-specific - Transcription | Cluster 38: Non-specific - Transcription | Cluster 17: Non-specific - RNA processing | Cluster 63: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | 82 | 6 |
ENSG00000005187 | ACSM3 | Acyl-CoA synthetase medium chain family member 3 | [
"Q53FZ2"
] | 16 | 20610243-20797581 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA041013"
] | [
"SA",
"SAH"
] | [
"Enzymes",
"Metabolic proteins",
"Predicted intracellular proteins"
] | [
"Fatty acid metabolism",
"Lipid metabolism"
] | [
"Ligase"
] | [] | [] | [] | [] | [] | null | Uncertain | null | 3 | null | null | Cluster 36: Eosinophils - Protein ubiquitination | Cluster 6: Non-specific - Immune response | Cluster 47: Leukemia - Hemostasis | Cluster 94: Gonadal somatic cells - Mixed function | Cluster 16: Liver & Kidney - Metabolism | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in many | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 83 | 7 |
ENSG00000005189 | REXO5 | RNA exonuclease 5 | [
"Q96IC2"
] | 16 | 20806429-20849665 | Evidence at protein level | Evidence at protein level | Evidence at transcript level | Evidence at protein level | [
"HPA040755",
"HPA040868",
"HPA066145"
] | [
"NEF-sp"
] | [
"Predicted intracellular proteins"
] | [] | [
"Exonuclease",
"Hydrolase",
"Nuclease",
"RNA-binding"
] | [] | [
"Nuclear membrane"
] | [
"Nucleoli",
"Endoplasmic reticulum"
] | [] | [] | Approved | Approved | null | 2 | null | null | Cluster 46: Basophils - Proteolysis | Cluster 4: Non-specific - mRNA splicing & Cell cycle | Cluster 47: Leukemia - Hemostasis | Cluster 53: Late primary spermatocytes - Meiotic division & transition | Cluster 57: Testis - Spermatogenesis | Tissue enriched | Detected in many | 9 | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enriched | Detected in some | 15 | 1 | 0 | 1 | [
"Glioblastoma Multiforme"
] | [] | [
"Glioblastoma Multiforme"
] | 84 | 5 |
End of preview. Expand in Data Studio
Human Protein Atlas Gene Annotations
This dataset contains a viewer-friendly gene-level Parquet table derived from the Human Protein Atlas JSONL source in this repository. Each row is one gene/protein entry. Repeated cancer-prognostic and RNA expression measurements are available as metadata tables.
Splits
The split is deterministic by Ensembl ID: sha256(ensembl_id) % 10. Bucket 0 is test; buckets 1 through 9 are train.
| Split | Rows |
|---|---|
| train | 18,138 |
| test | 2,024 |
| total | 20,162 |
Dataset Statistics
| Field | Value |
|---|---|
| Gene rows | 20,162 |
| Cancer prognostic metadata rows | 442,504 |
| RNA expression measurement rows | 149,150 |
Usage
pip install datasets
Load all splits:
from datasets import load_dataset
ds = load_dataset("LiteFold/HumanProteinAtlas")
print(ds)
print(ds["train"][0]["gene"])
Load one split:
from datasets import load_dataset
train = load_dataset("LiteFold/HumanProteinAtlas", split="train")
Filter genes with protein-level evidence:
from datasets import load_dataset
ds = load_dataset("LiteFold/HumanProteinAtlas", split="train")
protein_level = ds.filter(lambda row: row["evidence"] == "Evidence at protein level")
print(protein_level[0])
Load metadata tables directly:
import pandas as pd
from huggingface_hub import hf_hub_download
prognostics_path = hf_hub_download(
repo_id="LiteFold/HumanProteinAtlas",
repo_type="dataset",
filename="metadata/cancer_prognostics.parquet",
)
prognostics = pd.read_parquet(prognostics_path)
print(prognostics.head())
expression_path = hf_hub_download(
repo_id="LiteFold/HumanProteinAtlas",
repo_type="dataset",
filename="metadata/rna_expression_measurements.parquet",
)
expression = pd.read_parquet(expression_path)
print(expression.head())
Key Columns
| Column | Description |
|---|---|
ensembl_id |
Ensembl gene ID. |
gene |
Gene symbol. |
gene_description |
Gene/protein description. |
uniprot |
UniProt accession, when available. |
chromosome |
Chromosome. |
position |
Genomic position string. |
evidence |
Main HPA evidence level. |
hpa_evidence |
HPA-specific evidence level. |
uniprot_evidence |
UniProt evidence level. |
nextprot_evidence |
neXtProt evidence level. |
antibodies |
HPA antibody IDs. |
gene_synonyms |
Gene synonyms. |
protein_classes |
Protein class labels. |
biological_processes |
Biological process annotations. |
molecular_functions |
Molecular function annotations. |
disease_involvement |
Disease involvement labels. |
subcellular_main_locations |
Main subcellular locations. |
subcellular_additional_locations |
Additional subcellular locations. |
secretome_locations |
Secretome location annotations. |
secretome_functions |
Secretome function annotations. |
rna_tissue_specificity |
RNA tissue specificity category. |
rna_tissue_distribution |
RNA tissue distribution category. |
prognostic_cancer_count |
Number of cancers where the gene is prognostic. |
validated_prognostic_cancer_count |
Number of validated prognostic cancer entries. |
potential_prognostic_cancer_count |
Number of potential prognostic cancer entries. |
prognostic_cancers |
Cancer names with prognostic entries. |
split_bucket |
Deterministic split bucket from sha256(ensembl_id) % 10. |
Preparation
The normalization script used to create the Parquet files is included at scripts/prepare_hpa_dataset.py.
- Downloads last month
- 62